our projects
Project Rush
The Glioblastoma Research Organization announces Project Rush in proud collaboration with Lenox Hill Hospital’s Department of Neurosurgery’s Brain Tumor Center.

About Project Rush
Project Rush was inspired by the passing of Neil Peart, star-drummer for the Canadian Band, Rush.
Project Rush was inspired by the passing of Neil Peart, star-drummer for the Canadian Band, Rush. Led by Dr. John A. Boockvar along with the Lenox Hill Neurosurgery research team, Project Rush continues to explore the effectiveness of repeated superselective intra-arterial cerebral infusion (SIACI) of Avastin® (bevacizumab) with radiation and Temozolomide compared to radiation and Temozolomide alone in patients with newly diagnosed glioblastoma multiforme. Project Rush will assist in Phase 3 of this investigation. Previous Phases I & II have shown it is not only safe to deliver repeated doses of bevacizumab but has also shown significant progression-free and overall survival rates for newly diagnosed glioblastoma patients compared to the standard of care.
Project Rush, kicks off the partnership between The Glioblastoma Research Organization and Lenox Hill Hospital, in celebration of Brain Cancer Awareness Month 2021. This project marks The Glioblastoma Research Organization’s third fully funded project in its two-year lifespan. In addition to Project Rush, The Glioblastoma Research Organization continues to focus on developing campaigns to raise glioblastoma awareness, which aim to educate the masses on this devastating disease, as well as support its community of current glioblastoma warriors.
The Glioblastoma Research Organization is a 501(c)3 nonprofit charitable organization that works to raise awareness and funds for new global, cutting-edge research to find a cure for glioblastoma. #GBMRO
Supported by a $50,000 Glioblastoma Research Organization grant, Project Kenny pioneers the first fully implantable, rechargeable Tumor Treating Fields (TTF) device aimed at delivering 24/7 therapy without external hardware.
The Brain Tumor Funders' Collaborative (BTFC) announced a request for proposals for two-year, $500,000 research grants for multi-institutional, multi-disciplinary research projects focusing on liquid biopsy for primary brain tumors.
Project Build On, a research initiative underway at The University of Texas MD Anderson Cancer Center, explores strategic ways to target metabolic weaknesses of glioblastoma. Through innovative drug combinations, researchers aim to block key pathways that fuel cancer growth, offering new hope for patients with this aggressive disease.
Marking the GBMRO'S first funded research project of 2025, Project Rocket, formally known as Characterizing Glioblastoma Progression, Pseudoprogression, and Radiation Necrosis with Bedside Ultrasound Using Sonolucent Cranial Implants, led by Dr. Randy S. D’Amico, aims to identify key ultrasound markers that reveal whether the tumor is growing, healing, or experiencing other changes.
The Glioblastoma Biobank Project, formally known as Key LARGO (Key Longitudinal Associations with Risk and Glioblastoma Outcomes), is now live and open for enrollment!
The Glioblastoma Research Organization (GBMRO) announces its largest donation to date, $80,000, to fund Project DeLaRosa in partnership with Children's National Hospital.
Project Every Day Counts was launched with a $50,000 donation in collaboration with Gray for Glioblastoma Society to Children’s Hospital Los Angeles. The project honors Josh Wexler and the Wexler Family and their dedication to furthering GBM research.
Project Garcia marks GBMRO’s fourth fully funded Glioblastoma research project and the first in collaboration with Sylvester Comprehensive Cancer Center in Miami, Florida. The project includes novel research that uniquely applies a multiparametric intraoperative strategy to guide tumor resection and identify infiltrating tumor cells responsible for tumor recurrence.
The median age for diagnosis of Glioblastoma is 65, with patient prognosis known to decline with increased age. Christopher Hine, Ph.D., a researcher in the Department of Cardiovascular and Metabolic Sciences at Cleveland Clinic's Lerner Research Institute, has a theory that could explain why.
Funded by the Glioblastoma Research Organization, the laboratory of Dr. Steven Millward at the University of Texas MD Anderson Cancer Center has launched The Lee Project, which focuses on the directed evolution of vectors for treating GBM.
Brain tumors are the leading cause of cancer-related death in children. Of all the pediatric brain tumors, high-grade gliomas (HGG) remain the greatest challenge, with few treatment options available and a five-year survival rate of only 10-30 percent. A potential alternative to conventional treatments is to utilize a patient’s own immune system to attack tumor cells—immunotherapy.
Our Other Projects
The Glioblastoma Biobank Project, formally known as Key LARGO (Key Longitudinal Associations with Risk and Glioblastoma Outcomes), is now live and open for enrollment!
The Glioblastoma Research Organization (GBMRO) announces its largest donation to date, $80,000, to fund Project DeLaRosa in partnership with Children's National Hospital.
Project Every Day Counts was launched with a $50,000 donation in collaboration with Gray for Glioblastoma Society to Children’s Hospital Los Angeles. The project honors Josh Wexler and the Wexler Family and their dedication to furthering GBM research.
Project Garcia marks GBMRO’s fourth fully funded Glioblastoma research project and the first in collaboration with Sylvester Comprehensive Cancer Center in Miami, Florida. The project includes novel research that uniquely applies a multiparametric intraoperative strategy to guide tumor resection and identify infiltrating tumor cells responsible for tumor recurrence.
The median age for diagnosis of Glioblastoma is 65, with patient prognosis known to decline with increased age. Christopher Hine, Ph.D., a researcher in the Department of Cardiovascular and Metabolic Sciences at Cleveland Clinic's Lerner Research Institute, has a theory that could explain why.
Funded by the Glioblastoma Research Organization, the laboratory of Dr. Steven Millward at the University of Texas MD Anderson Cancer Center has launched The Lee Project, which focuses on the directed evolution of vectors for treating GBM.